Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Revenue projections:

Revenue projections for ISRG
Revenue projections for ISRG

ISRG's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 4.61000
forwardPE 34.54159
debtToEquity 0.00000
earningsGrowth 0.18800
revenueGrowth 0.23000
grossMargins 0.66292
operatingMargins 0.30868
trailingEps 8.22000
forwardEps 11.78637

ISRG's current ratio of 4.61 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. ISRG's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
ISRG's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that ISRG is expected to continue expanding its business and boosting its financial performance in the coming periods.
Intuitive Surgical, Inc.'s positive gross and operating margins indicate healthy profitability. These margins reflect the company's ability to generate income efficiently from its operations, signaling strong financial performance and effective cost management.
ISRG's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that ISRG is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for ISRG
Price projections for ISRG

The price of ISRG has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.

Insider Transactions:

Insider Transactions for ISRG
Insider Transactions for ISRG


34 ISRG transactions were recorded, when the market price was 506.3923528334674.There were no sell transactions throughout the period under consideration.The higher volume of buys compared to sells near current ISRG price levels may suggest optimism among investors. This could point to a favorable market outlook, as more people are willing to invest at these prices, anticipating potential future growth or strong performance.

Recommendation changes over time:

Recommendations trend for ISRG
Recommendations trend for ISRG


Analysts have shown a buy bias for ISRG, marking it as a favorable investment option. This could inspire investors to see ISRG as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.